Treatment of hemangiomas of infancy
Hemangiomas of infancy are the most common tumors of childhood. They are clinically heterogeneous and as such require individualized treatment plans. Although there are no Food and Drug Administration (FDA)-approved agents for treatment of hemangiomas of infancy, there are many widely used therapeutic options available. This review highlights the treatments currently in use and the factors that direct treatment.
Document Type: Research Article
Affiliations: Department of Dermatology, Medical College of Wisconsin, Milwaukee, WI
Publication date: March 1, 2005